Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration.
Curr Oncol. 2023 Mar 28;30(4):3776-3786. doi: 10.3390/curroncol30040286.
Curr Oncol. 2023.
PMID: 37185399
Free PMC article.
A multicenter review of infusion-related reactions to daratumumab for relapsed multiple myeloma in the real world setting.
Geirnaert M, Howarth J, Martin K, Ricard C, Streilein S, Wasney D, Dao V, Kotb R, Rimmer E, Minuk L.
Geirnaert M, et al. Among authors: wasney d.
J Oncol Pharm Pract. 2021 Jun;27(4):907-910. doi: 10.1177/1078155220967738. Epub 2020 Oct 27.
J Oncol Pharm Pract. 2021.
PMID: 33108988
Item in Clipboard
Off-label infusion of biosimilar bevacizumab: A provincial experience.
Geirnaert M, Howarth J, Kellett C, Martin K, Streilein S, Ricard C, Wasney D, Niraula S.
Geirnaert M, et al. Among authors: wasney d.
J Oncol Pharm Pract. 2020 Oct;26(7):1683-1685. doi: 10.1177/1078155220945374. Epub 2020 Jul 29.
J Oncol Pharm Pract. 2020.
PMID: 32727322
Item in Clipboard
Cite
Cite